Mutual aid ↓save

Toshihiko Doi, Atsushi Ohtsu, Nozomu Fuse…. (2013). Phase 1 study of trebananib (AMG 386), an angiogenesis targeting angiopoietin-1/2 antagonist, in Japanese patients with advanced solid tumors. , 71(1), 227–235. doi:10.1007/s00280-012-2000-1 

An interview with Sci-Hub Founder Alexandra Elbakyan,Who exactly should pay for academic research